Simon Amy
Transaction: 07/27/2026
SELL
Change
-16,667
Price
$25.74
Filing
07/29/2026
Type
SELL
Beam Therapeutics Inc.
BEAM • Biotechnology
$24.93
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$2.60B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 15.0%Manageable debt level · 0.24Healthy liquidity · 13.09Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:51 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$24.93
Change0.00%
Shares Out104.33M
Market Cap$2.60B
Enterprise Value$1.55B
52W Range15.60 - 38.26
Beta2.18
P/E-30.45
P/S16.72
P/B2.44
P/FCF-6.98
EV/Sales9.95
Price$24.93
Change0.00%
Shares Out104.33M
Market Cap$2.60B
Enterprise Value$1.55B
52W Range15.60 - 38.26
Beta2.18
P/E-30.45
P/S16.72
P/B2.44
P/FCF-6.98
EV/Sales9.95
EV/EBITDA-20.72
EV/FCF-4.15
Earnings Yield-3.28%
FCF Yield-14.33%
Dividend Yield0.00%
Gross Margin84.05%
Oper. Margin-2.75%
Profit Margin-57.24%
Debt/Eq0.24
Current Ratio13.09
Quick Ratio13.09
Target$59.50
Target Upside138.67%
Target Median$59.50
Target Range39.00 - 80.00
Volume2.05M
Avg Volume2.33M
EPS Surprise-0.04
Investment DNA
How strong this company looks for long-term investors
49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
52/100
Why this score▼
Positive revenue growth · 15.0%Manageable debt level · 0.24Healthy liquidity · 13.09Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 27 analyst votes · 2026-10-20
81/100
Bullish
Bullish
18
Hold
8
Bearish
1
Price Target
2026-08-06
Low
$26.00
Mean
$54.75
Median
$56.50
High
$80.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Simon Amy
Transaction: 06/30/2026
SELL
Change
-373
Price
$34.73
Filing
07/02/2026
Type
SELL
Evans John M.
Transaction: 06/30/2026
SELL
Change
-25,000
Price
$1.03
Filing
07/01/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Simon Amy | SELL | -16,667 | $25.74 | 07/27/2026 | 07/29/2026 |
| Simon Amy | SELL | -373 | $34.73 | 06/30/2026 | 07/02/2026 |
| Evans John M. | SELL | -25,000 | $1.03 | 06/30/2026 | 07/01/2026 |
| Evans John M. | SELL | -1,900 | $34.84 | 06/30/2026 | 07/01/2026 |
| Evans John M. | SELL | -18,663 | $0.67 | 06/29/2026 | 07/01/2026 |
| Evans John M. | SELL | -11,579 | $35.91 | 06/29/2026 | 07/01/2026 |
| FMR LLC | SELL | -251,488 | $35.26 | 06/26/2026 | 06/29/2026 |
| FMR LLC | SELL | -33,372 | $35.12 | 06/25/2026 | 06/29/2026 |
| Ciaramella Giuseppe | SELL | -6,505 | $0.67 | 06/17/2026 | 06/22/2026 |
| Ciaramella Giuseppe | BUY | +6,505 | $0.67 | 06/17/2026 | 06/22/2026 |
| COOPER GRAHAM K | BUY | +19,676 | $29.55 | 06/03/2026 | 06/05/2026 |
| Guindo Chirfi | BUY | +19,676 | $29.55 | 06/03/2026 | 06/05/2026 |
| Fishman Mark | BUY | +19,676 | $29.55 | 06/03/2026 | 06/05/2026 |
| MARAGANORE JOHN | BUY | +19,676 | $29.55 | 06/03/2026 | 06/05/2026 |
| Walsh Kathleen E | BUY | +19,676 | $29.55 | 06/03/2026 | 06/05/2026 |
| Shaw Christi | BUY | +19,676 | $29.55 | 06/03/2026 | 06/05/2026 |
| Ciaramella Giuseppe | SELL | -11,810 | $24.58 | 04/01/2026 | 04/06/2026 |
| Bellon Christine | SELL | -5,956 | $24.58 | 04/01/2026 | 04/06/2026 |
| Cavanagh Bethany J | SELL | -3,242 | $24.58 | 04/01/2026 | 04/06/2026 |
| Simon Amy | SELL | -6,700 | $24.58 | 04/01/2026 | 04/06/2026 |